RyMat Inc
Stuart Silverman
CEO & Founder
(803) 397-8087

RyMat Inc.

Solution Provider to the Pharmaceutical Industry

Apothecations

Pharmaceutical Industry Topics and Tips

view:  full / summary

Brief Look At Different Types Of Pharmaceutical Companies

Posted on August 7, 2016 at 7:50 AM Comments comments (2)

Our Aging Population and Increasing Dependence on Prescription Medicines

Posted on March 12, 2016 at 4:10 PM Comments comments (3)


Better Living Through Chemistry

 

Our Aging Population and Increasing Dependence on Prescription Medicines

 

As of December 2, 2015, the United States has a total resident population of 322,267,564, making it the third most populous country in the world.

Read Full Post »

Breakthrough Therapy Designation

Posted on March 11, 2016 at 3:55 PM Comments comments (0)


RyMat Inc. FDA Drug Approval & Applications Series

Volume V

Breakthrough Therapy Designation

Breakthrough therapy is a United States Food and Drug Administra...

Read Full Post »

FDA Orphan Drug Designation (with editorial)

Posted on March 6, 2016 at 4:10 PM Comments comments (0)


RyMat Inc. FDA Drug Approval & Applications Series

Volume IV

FDA Orphan Drug Designation

An orphan drug is a pharmaceutical agent that has been developed specifically...

Read Full Post »

FDA Priority Review (plus editorial comments)

Posted on March 5, 2016 at 3:10 PM Comments comments (0)


RyMat Inc. FDA Drug Approval & Applications Series

Volume III

FDA Priority Review (plus editorial comments)

The priority review is an incentive for companies to invest in new drugs and vacc...

Read Full Post »

FDA Fast Track Approval Program

Posted on February 28, 2016 at 1:15 PM Comments comments (0)



RyMat Inc. FDA Drug Approval & Applications Series

Volume II

FDA Fast Track Approval Program

Section 506(b) of the FD&C Act provides for the designation of a drug as a fast track product &...

Read Full Post »

FDA Accelerated Approval Program

Posted on February 27, 2016 at 2:55 PM Comments comments (0)


FDA Drug Approval & Applications Series

Volume I

FDA Accelerated Approval Program

The accelerated approval provisions of FDASIA in section 506(c) of the FD&C Act provide that FDA may grant accelerated approval to:

Read Full Post »

505(b)(2) - A Primer

Posted on February 12, 2016 at 11:45 AM Comments comments (0)

Click on this link for the full article (downloadable): http://1drv.ms/1SLNf9U

The Zika Virus - A Primer

Posted on February 11, 2016 at 3:45 PM Comments comments (0)

Click on link to be taken to the article: http://1drv.ms/1Skd2FG

Validation In Drug Manufacturing

Posted on February 2, 2016 at 4:35 AM Comments comments (0)



Validation is a process of establishing documentary evidence demonstrating that a procedure, process, or activity carried out in production or testing maintains the desired level of compliance at all stages. In Pharma Industry it is very important apart from final testing and compliance of product with standard that the process adapted to produce itself must assure that process will consistent...

Read Full Post »

Rss_feed